Literature DB >> 30057996

Novel mosaic mutation in the dystrophin gene causing distal asymmetric muscle weakness of the upper limbs and dilated cardiomyopathy.

Joana Ribeiro1, Olinda Rebelo1, Ana Fernández-Marmiesse2, Luís Negrão1.   

Abstract

A group of heterogeneous muscle diseases are caused by dystrophin gene (DMD) mutations. We hereby present a male patient with a diagnosis of symptomatic dilated cardiomyopathy at 44 years-old who developed, soon after, weakness of distal right upper limb. At the age of 58, neurological examination revealed severe atrophy of right thenar muscles, flexion contractures on the right elbow, wrist and fingers, bilateral calf hypertrophy, myotatic areflexia in the upper limbs and hyporeflexia in the lower limbs. Manual muscle examination showed distal weakness of right upper limb muscles, severe on abductor pollicis brevis and extensor pollicis longus, and milder on interossei, finger extensors and brachioradialis muscles. Further testing revealed CK of 1500 U/L, a myopathic pattern on electromyography, and myopathic changes on right deltoid muscle biopsy, with immunohistochemistry showing focal sub-expression of dystrophin. Cardiac workup revealed a severe reduction in left ventricular ejection fraction, with a left ventricle of increased dimensions and global hypo-contractibility. A next-generation sequencing based panel for muscular diseases was performed and a nonsense mutation (c.C7525T) was identified in exon 51 of DMD gene, present in 70% of the gene readings (consistent with mosaicism).

Entities:  

Keywords:  dilated cardiomyopathy; dystrophin gene; next generation sequencing

Mesh:

Substances:

Year:  2018        PMID: 30057996      PMCID: PMC6060426     

Source DB:  PubMed          Journal:  Acta Myol        ISSN: 1128-2460


  10 in total

Review 1.  Overview of the muscular dystrophies.

Authors:  Anthony A Amato; Robert C Griggs
Journal:  Handb Clin Neurol       Date:  2011

2.  Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study.

Authors:  E M Hoogerwaard; E Bakker; P F Ippel; J C Oosterwijk; D F Majoor-Krakauer; N J Leschot; A J Van Essen; H G Brunner; P A van der Wouw; A A Wilde; M de Visser
Journal:  Lancet       Date:  1999-06-19       Impact factor: 79.321

3.  Isolated cardiomyopathy caused by a DMD nonsense mutation in somatic mosaicism: genetic normalization in skeletal muscle.

Authors:  J Juan-Mateu; C Paradas; M Olivé; E Verdura; E Rivas; L González-Quereda; M J Rodríguez; M Baiget; P Gallano
Journal:  Clin Genet       Date:  2011-12-13       Impact factor: 4.438

4.  Clinical and genetic characterization of manifesting carriers of DMD mutations.

Authors:  Payam Soltanzadeh; Michael J Friez; Diane Dunn; Andrew von Niederhausern; Olga L Gurvich; Kathryn J Swoboda; Jacinda B Sampson; Alan Pestronk; Anne M Connolly; Julaine M Florence; Richard S Finkel; Carsten G Bönnemann; Livija Medne; Jerry R Mendell; Katherine D Mathews; Brenda L Wong; Michael D Sussman; Jonathan Zonana; Karen Kovak; Sidney M Gospe; Eduard Gappmaier; Laura E Taylor; Michael T Howard; Robert B Weiss; Kevin M Flanigan
Journal:  Neuromuscul Disord       Date:  2010-07-13       Impact factor: 4.296

5.  Somatic mosaicism due to a reversion variant causing hemi-atrophy: a novel variant of dystrophinopathy.

Authors:  Jaya Punetha; Simin Mansoor; Tulio E Bertorini; Akanchha Kesari; Kristy J Brown; Eric P Hoffman
Journal:  Eur J Hum Genet       Date:  2016-03-09       Impact factor: 4.246

Review 6.  The medical genetics of dystrophinopathies: molecular genetic diagnosis and its impact on clinical practice.

Authors:  Alessandra Ferlini; Marcella Neri; Francesca Gualandi
Journal:  Neuromuscul Disord       Date:  2012-10-30       Impact factor: 4.296

Review 7.  Dystrophinopathies.

Authors:  John F Brandsema; Basil T Darras
Journal:  Semin Neurol       Date:  2015-10-06       Impact factor: 3.420

Review 8.  Somatic mosaicism in the human genome.

Authors:  Donald Freed; Eric L Stevens; Jonathan Pevsner
Journal:  Genes (Basel)       Date:  2014-12-11       Impact factor: 4.096

9.  Somatic mosaicism for Duchenne dystrophy: evidence for genetic normalization mitigating muscle symptoms.

Authors:  Akanchha Kesari; Robert Neel; Lynne Wagoner; Brennan Harmon; Christopher Spurney; Eric P Hoffman
Journal:  Am J Med Genet A       Date:  2009-07       Impact factor: 2.802

Review 10.  Dystrophin and mutations: one gene, several proteins, multiple phenotypes.

Authors:  Francesco Muntoni; Silvia Torelli; Alessandra Ferlini
Journal:  Lancet Neurol       Date:  2003-12       Impact factor: 44.182

  10 in total
  2 in total

1.  EMQN best practice guidelines for genetic testing in dystrophinopathies.

Authors:  Carl Fratter; Raymond Dalgleish; Stephanie K Allen; Rosário Santos; Stephen Abbs; Sylvie Tuffery-Giraud; Alessandra Ferlini
Journal:  Eur J Hum Genet       Date:  2020-05-18       Impact factor: 4.246

2.  Genetic Modifiers of Hereditary Neuromuscular Disorders and Cardiomyopathy.

Authors:  Sholeh Bazrafshan; Hani Kushlaf; Mashhood Kakroo; John Quinlan; Richard C Becker; Sakthivel Sadayappan
Journal:  Cells       Date:  2021-02-08       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.